Stress Ball Intervention During Active Labor

September 28, 2026 updated by: Hediye Karakoç, KTO Karatay University

Stress Ball Use as a Tactile Coping Intervention During Active Labour: Effects on Maternal Self-Efficacy in a Randomized Controlled Trial

This randomized controlled trial evaluates the effect of a stress ball intervention used during the active phase of labor primarily on maternal self-efficacy, while secondarily examining childbirth comfort, labor pain intensity, and labor progress. Labor pain is a multidimensional experience influenced by physiological and psychological factors, including coping and perceived control. Simple non-pharmacological interventions may support women's coping and active participation during labor.

Participants in the intervention group use a stress ball during uterine contractions throughout the active phase of labor in addition to routine midwifery care, while participants in the control group receive routine midwifery care alone. Maternal self-efficacy and childbirth comfort are assessed at baseline during the active phase of labor and within 24 hours postpartum. Labor pain intensity is assessed using a Visual Analogue Scale at predefined cervical dilatation levels (5, 6, 8, and 10 cm). Labor progress parameters, including uterine contraction characteristics and fetal heart rate, are also monitored throughout the active phase.

The primary objective is to determine whether stress ball use during active labor improves maternal self-efficacy. Secondary objectives are to evaluate its effects on childbirth comfort and labor pain intensity and to examine whether the intervention adversely affects physiological labor progress.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

This study is a single-center, parallel-group randomized controlled trial designed to evaluate the effects of a stress ball intervention during the active phase of labor. The intervention is based on theoretical concepts of distraction, active coping, perceived control, and self-efficacy. The primary objective is to determine whether stress ball use during active labor improves maternal self-efficacy. Secondary objectives are to evaluate its effects on childbirth comfort and labor pain intensity and to examine whether the intervention adversely affects physiological labor progress.

Eligible participants are low-risk pregnant women with singleton pregnancies at 37-42 weeks of gestation who are in the active phase of spontaneous labor (cervical dilatation ≥5 cm). Following baseline assessment, participants are randomized in a 1:1 ratio to either the intervention group or the control group. The intervention group receives routine midwifery care plus stress ball use during uterine contractions throughout the active phase of labor, whereas the control group receives routine midwifery care alone.

Maternal self-efficacy, the primary outcome, is assessed at baseline during the active phase of labor and within 24 hours postpartum. Childbirth comfort is assessed at the same time points as a secondary outcome. Labor pain intensity is assessed using a 100-mm Visual Analogue Scale at cervical dilatation levels of 5, 6, 8, and 10 cm. Labor progress parameters, including cervical dilatation, uterine contraction characteristics, and fetal heart rate, are monitored throughout the active phase of labor to evaluate physiological labor progression and safety.

For the primary outcome, between-group differences in post-intervention maternal self-efficacy are evaluated while accounting for baseline self-efficacy. Childbirth comfort is evaluated similarly as a secondary outcome. Repeated measurements of labor pain across cervical dilatation levels are analyzed to examine group differences, changes across labor progression, and the group-by-dilatation interaction.

The study is designed to determine whether stress ball use during active labor can support maternal self-efficacy and coping while evaluating its effects on childbirth comfort and pain intensity and ensuring that the intervention does not adversely affect physiological labor progression.

Study Type

Interventional

Enrollment (Actual)

78

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Aged 18-35 years,
  • Singleton pregnancy at 37-42 weeks of gestation,
  • In the active phase of spontaneous labor with cervical dilatation ≥5 cm,
  • No mental or physical disability that would prevent participation in the study,
  • Able to speak and understand Turkish,
  • Provided voluntary informed consent to participate in the study.

Exclusion Criteria:

  • High-risk pregnancy,
  • Presence of a systemic disease or medical or obstetric complication,
  • Use of epidural analgesia or other pharmacological pain management during labor.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Stress Ball + Routine Midwifery Care

Participants receive routine midwifery care plus stress ball use throughout the active phase of labor. Participants are instructed to rhythmically squeeze the stress ball during uterine contractions and release it during the relaxation periods between contractions. Stress ball use is continued throughout the active phase of labor in addition to routine midwifery care.

A handheld stress ball used during uterine contractions throughout the active phase of labor to support coping through distraction and enhance perceived control.

No Intervention: Routine Midwifery Care (Control)

Participants receive routine midwifery care only, including standard labor monitoring and supportive care according to hospital protocol.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal Self-Efficacy
Time Frame: Baseline during the active phase of labor and within 24 hours postpartum.

Maternal self-efficacy is assessed using the 17-item Self-Efficacy Scale. Each item is rated on a 5-point Likert scale, yielding a total score ranging from 17 to 85. Higher total scores indicate higher perceived self-efficacy.

Baseline during the active phase of labor and within 24 hours postpartum.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Childbirth Comfort
Time Frame: Baseline (active phase onset) and within 24 hours postpartum.

Childbirth comfort is assessed using the 9-item Childbirth Comfort Scale. Each item is rated on a 5-point Likert scale, yielding a total score ranging from 9 to 45. Higher total scores indicate higher levels of childbirth comfort.

Baseline (active phase onset) and within 24 hours postpartum.
Labor Pain Intensity
Time Frame: At 5, 6, 8, and 10 cm cervical dilatation during the active phase of labor.

Labor pain intensity is assessed using a 100-mm Visual Analogue Scale (VAS), ranging from 0 mm ("no pain") to 100 mm ("worst imaginable pain"). Higher scores indicate greater perceived pain intensity.

At 5, 6, 8, and 10 cm cervical dilatation during the active phase of labor.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 3, 2025

Primary Completion (Actual)

November 30, 2025

Study Completion (Actual)

November 30, 2025

Study Registration Dates

First Submitted

February 28, 2026

First Submitted That Met QC Criteria

February 28, 2026

First Posted (Actual)

March 5, 2026

Study Record Updates

Last Update Posted (Actual)

October 1, 2026

Last Update Submitted That Met QC Criteria

September 28, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe